Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Peripherally Inserted Central Catheter Safety and Efficacy in Acute Myeloid Leukemia: A Monocentric Experience from the Hematology of Cagliari

Daniele Derudas, Sabrina Chiriu, Claudio Romani, Federica Pilo, Martina Pettinau, Giuseppe Longhitano, Daniela Ibba, Loredana Aracu, Giorgio La Nasa

Blood (2023) 142 (Supplement 1): 7289.

https://doi.org/10.1182/blood-2023-187138

Published: 2023

Journal Articles

Peripherally Inserted Central Catheter Safety and Efficacy in Acute Lymphoblastic Leukemias: A 16-Years Monocentric Experience

Daniele Derudas, Sabrina Chiriu, Claudio Romani, Federica Pilo, Martina Pettinau, Giuseppe Longhitano, Daniela Ibba, Loredana Aracu, Giorgio La Nasa

Blood (2023) 142 (Supplement 1): 7255.

https://doi.org/10.1182/blood-2023-187272

Published: 2023

Journal Articles

Thromboembolic Complications PICC-Related in Adult Patients Affected By Hematologic Diseases: A 13-Years Monocentric Experience

Daniele Derudas, Stefania Massidda, Maria Pina Simula, Daniela Dessì, Sara Veronica Usai, Claudio Romani, Giuseppe Longhitano, Daniela Ibba, Loredana Aracu, Giorgio La Nasa

Blood (2022) 140 (Supplement 1): 11306–11307.

https://doi.org/10.1182/blood-2022-166952

Published: 2022

Journal Articles

A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-center Study of FLT3 mutated AML patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitors Administration in the Real-Life Clinical Practice

Blood (2020) 136 (Supplement 1): 32–34.

https://doi.org/10.1182/blood-2020-139981

Published: 2020

Journal Articles

Identification of a Predictive Pre-Chemotherapy Score for Febrile Neutropenia - the Fnipi INDEX

Marco Sanna, Giovanni Caocci, MD, Antonio Ledda, Elisabetta Belardinelli, Pietro Garau, Alessandro Fanni, MD, Claudio Romani, Giorgio La Nasa, MD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-134659

Published: 2020

Journal Articles

Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)

Blood (2016) 128 (22): 176.

https://doi.org/10.1182/blood.V128.22.176.176

Published: 2016

Journal Articles

Levels of Minimal Residual Disease Prior to Transplant Influence Outcome of Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Blood (2015) 126 (23): 4374.

https://doi.org/10.1182/blood.V126.23.4374.4374

Published: 2015

Journal Articles

Autologous Stem Cell Transplantation in Acute Myeloid Leukemia; A Single Centre “Real Life” Study

Donatella Baronciani, MD, Cristina Depau, MD, Clara Targhetta, MD, Sara Veronica Usai, MD, Anna Angela Di Tucci, MD, Claudio Romani, MD, Igor Tandurella, PhD, Emanuele Angelucci, MD

Blood (2014) 124 (21): 5905.

https://doi.org/10.1182/blood.V124.21.5905.5905

Published: 2014

Journal Articles

Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte ® ) In Adult Acute Lymphoblastic Leukemia (ALL)

Blood (2013) 122 (21): 3901.

https://doi.org/10.1182/blood.V122.21.3901.3901

Published: 2013

Journal Articles

Long-Term Health Related Quality Of Life and Symptom Burden In Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid (ATRA) and Chemotherapy

Blood (2013) 122 (21): 770.

https://doi.org/10.1182/blood.V122.21.770.770

Published: 2013

Journal Articles

In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Imatinib (IM) and Chemotherapy in Combination Improve Remission Rate, Stem Cell Transplantation Rate and Long-Term Outcome

Tamara Intermesoli, MD, Chiara Cattaneo, MD, Enrico Maria Pogliani, MD, Eros Di Bona, MD, Claudio Romani, MD, Vincenzo Cassibba, MD, Agostino Cortelezzi, MD, Francesco Mannelli, MD, Fabio Ciceri, MD, Daniele Mattei, MD, Orietta Spinelli, BiolSC, Manuela Tosi, BiolSC, Elena Oldani, BiolSC, Alessandro Rambaldi, MD, Renato Bassan, MD

Blood (2012) 120 (21): 662.

https://doi.org/10.1182/blood.V120.21.662.662

Published: 2012

Journal Articles

High Cure Rates in Burkitt Leukemia and Lymphoma: NILG Study of the German Short Intensive Rituximab-Chemotherapy Program

Blood (2012) 120 (21): 1494.

https://doi.org/10.1182/blood.V120.21.1494.1494

Published: 2012

Journal Articles

Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL).

Renato Bassan, MD, Orietta Spinelli, BiolSC, Elena Oldani, BiolSC, Manuela Tosi, BiolSC, Barbara Peruta, BiolSC, Erika Borlenghi, MD, Enrico Maria Pogliani, MD, Eros Di Bona, MD, Vincenzo Cassibba, MD, Anna Maria Scattolin, MD, Claudio Romani, MD, Fabio Ciceri, MD, Agostino Cortelezzi, MD, Giacomo Gianfaldoni, MD, Daniele Mattei, MD, Ernesta Audisio, MD, Tamara Intermesoli, Alessandro Rambaldi, MD

Blood (2012) 120 (21): 2573.

https://doi.org/10.1182/blood.V120.21.2573.2573

Published: 2012

Journal Articles

In Adult Acute Lymphoblastic Leukemia (ALL) Different Minimal Residual Disease (MRD) Levels Predict Clinical Outcome in All Patients and Response to Allogeneic/Autologous Transplantation in MRD-Positive Patients.

Blood (2012) 120 (21): 2493.

https://doi.org/10.1182/blood.V120.21.2493.2493

Published: 2012

Journal Articles

Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07

Blood (2010) 116 (21): 2131.

https://doi.org/10.1182/blood.V116.21.2131.2131

Published: 2010

Journal Articles

Efficacy of Low Dose Clofarabine Plus Intermediate Dose Cytarabine In An Unselected AML Refractory/Relapsed Adult Population

Claudio Romani, MD, Emanuele Angelucci, MD, Barbara Scappini, MD, Mario Petrini, MD, Martina Pettinau, Filippo Marmont, Francesco Caracciolo, Ernesta Audiosio, MD, Alberto Bosi

Blood (2010) 116 (21): 4349.

https://doi.org/10.1182/blood.V116.21.4349.4349

Published: 2010

Journal Articles

Improved Clinical Outcome of Adult Patients with Ph+ ALL After a Combined Imatinib-Chemotherapy Induction/Consolidation Program Followed by Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Prospective Study of the Northern Italy Leukemia Group

Blood (2010) 116 (21): 682.

https://doi.org/10.1182/blood.V116.21.682.682

Published: 2010

Journal Articles

Short Chemotherapy-Phased Imatinib (IM) Pulses Improve Long-Term Outcome of Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Blood (2009) 114 (22): 2029.

https://doi.org/10.1182/blood.V114.22.2029.2029

Published: 2009

Journal Articles

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Blood (2009) 113 (18): 4153–4162.

https://doi.org/10.1182/blood-2008-11-185132

Published: 2009

Includes: Supplemental data

Journal Articles

Acute Zoster Pain (AZP) and Post-Herpetic Neuralgia (PHN) in the Course of Lymphoproliferative Disorders (LPD): Durable Pain Relief Provided by Oxycodone in Patients Unresponsive to Standard Therapy.

Pasquale Niscola, MD, Claudio Romani, MD, Alessio Pio Perrotti, MD, Giovanni Del Poeta, MD, Claudio Cartoni, MD, Massimiliano Palombi, MD, Marco Giovannini, MD, Luca Cupelli, MD, Paolo De Fabritiis, MD

Blood (2006) 108 (11): 5500.

https://doi.org/10.1182/blood.V108.11.5500.5500

Published: 2006

NARROW

Peripherally Inserted Central Catheter Safety and Efficacy in Acute Myeloid Leukemia: A Monocentric Experience from the Hematology of Cagliari

Peripherally Inserted Central Catheter Safety and Efficacy in Acute Lymphoblastic Leukemias: A 16-Years Monocentric Experience

Thromboembolic Complications PICC-Related in Adult Patients Affected By Hematologic Diseases: A 13-Years Monocentric Experience

A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-center Study of FLT3 mutated AML patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitors Administration in the Real-Life Clinical Practice

Identification of a Predictive Pre-Chemotherapy Score for Febrile Neutropenia - the Fnipi INDEX

Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)

Levels of Minimal Residual Disease Prior to Transplant Influence Outcome of Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Autologous Stem Cell Transplantation in Acute Myeloid Leukemia; A Single Centre “Real Life” Study

Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte ® ) In Adult Acute Lymphoblastic Leukemia (ALL)

Long-Term Health Related Quality Of Life and Symptom Burden In Patients With Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid (ATRA) and Chemotherapy

In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Imatinib (IM) and Chemotherapy in Combination Improve Remission Rate, Stem Cell Transplantation Rate and Long-Term Outcome

High Cure Rates in Burkitt Leukemia and Lymphoma: NILG Study of the German Short Intensive Rituximab-Chemotherapy Program

Early Response Dynamics Including Minimal Residual Disease (MRD) and Adherence to Risk/MRD-Oriented Therapy Are Major Outcome Determinants in Adult Ph-Negative Acute Lymphoblastic Leukemia (ALL).

In Adult Acute Lymphoblastic Leukemia (ALL) Different Minimal Residual Disease (MRD) Levels Predict Clinical Outcome in All Patients and Response to Allogeneic/Autologous Transplantation in MRD-Positive Patients.

Pediatric-Type Therapy Including Lineage-Targeted Methotrexate to Improve Early Minimal Residual Disease Response and Survival In Adult Acute Lymphoblastic Leukemia (ALL): Interim Analysis of Northern Italy Leukemia Group Study 10/07

Efficacy of Low Dose Clofarabine Plus Intermediate Dose Cytarabine In An Unselected AML Refractory/Relapsed Adult Population

Improved Clinical Outcome of Adult Patients with Ph+ ALL After a Combined Imatinib-Chemotherapy Induction/Consolidation Program Followed by Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Prospective Study of the Northern Italy Leukemia Group

Short Chemotherapy-Phased Imatinib (IM) Pulses Improve Long-Term Outcome of Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Acute Zoster Pain (AZP) and Post-Herpetic Neuralgia (PHN) in the Course of Lymphoproliferative Disorders (LPD): Durable Pain Relief Provided by Oxycodone in Patients Unresponsive to Standard Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only